Skip to main content
OpenTrials

Clinical trial condition

Renal Cell Carcinoma

Explore clinical trials studying Renal Cell Carcinoma. Study availability and eligibility vary by location and protocol.

412 public trials 75 recruiting studies
Refine in advanced search Browse all conditions

Renal Cell Carcinoma trial results

Active, Not Recruiting

Evaluation of a Simple-Prep Controlled Embolic

NCT06453642

Conditions
Adenocarcinoma, Angiomyolipoma, Bone Diseases, +30 more
Locations
  • University of California San Diego Altman Clinical and Translation Research Institute La Jolla, California, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • Northwestern University Chicago, Illinois, United States
  • Indiana University Hospital Indianapolis, Indiana, United States
View all 20 locations
View Trial Details
Active, Not Recruiting

177LuPSMA in Renal Cell Carcinoma

NCT06964958

Conditions
Adenocarcinoma, Advanced Clear Cell Renal Cell Carcinoma, Carcinoma, +16 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma

NCT02811861

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Stanford School of Medicine Stanford, California, United States
  • Boca Raton Community Hospital Boca Raton, Florida, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • University of Miami Miami, Florida, United States
View all 183 locations
View Trial Details
Active, Not Recruiting

Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population

NCT05863052

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +46 more
Locations
  • Arizona Cancer Center at the Unvieristy of Arizona Tucson, Arizona, United States
  • University of New Mexico Comprehensive Cancer Center Albuquerque, New Mexico, United States
  • Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • Monument Health Cancer Care Institute Rapid City, South Dakota, United States
View Trial Details
Active, Not Recruiting

P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors

NCT05239143

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Cancer, +66 more
Locations
  • University of California, Irvine Medical Center Irvine, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • University of California, San Diego San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

A Study of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Participants With Advanced Kidney Cancer

NCT03873402

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Local Institution - 0013 Washington D.C., District of Columbia, United States
  • Local Institution - 0053 Athens, Georgia, United States
  • Local Institution - 0066 Boston, Massachusetts, United States
  • Local Institution - 0088 Boston, Massachusetts, United States
View all 78 locations
View Trial Details
Active, Not Recruiting

QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors

NCT03228667

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +79 more
Locations
  • Alaska Clinical Research Center Anchorage, Alaska, United States
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • Chan Soon-Shiong Institute for Medicine El Segundo, California, United States
  • MemorialCare Health System Fountain Valley, California, United States
View all 35 locations
View Trial Details

Related conditions